American Herbal Products Association (AHPA) > Resources > Regulations > Government Advocacy

Recent AHPA Advocacy

USDA Hemp Production Program Listening Session

USDA Hemp Production Program Listening Session

A recording is now available

AHPA participated in the “2018 Farm Bill Listening Session on Domestic Hemp Production Program” conducted by the U.S.Department of Agriculture (USDA) on March 13, 2019. The event provided an opportunity for the agency to receive feedback directly from stakeholders regarding development of new regulations implementing the hemp provisions of the 2018 Farm Bill. The format allowed for registered participants to provide up to three minutes of public comment.
AHPA participates in AOAC Mid-Year Meeting

AHPA participates in AOAC Mid-Year Meeting

Chief Science Officer Holly Johnson, Ph.D., represents members at AOAC

AHPA Chief Science Officer Holly Johnson, Ph.D., represented member interests at the 9th Annual AOAC INTERNATIONAL Midyear Meeting and Analytical Solutions Forum held March 11-14 outside Washington, DC.
IADSA update on international supplement regulations

IADSA update on international supplement regulations

IADSA February 2019 Newsflash

This issue of the IADSA Newsflash includes an update on the EU banning yohimbe and consulting on regulatory limits for pyrrolizidine alkaloids in teas, honey, and food supplement products.
Free GRMA webinar on new ANSI-accredited auditing standards

Free GRMA webinar on new ANSI-accredited auditing standards

Webinar recording and handouts

AHPA partnered with the Global Retailer and Manufacturer Alliance (GRMA) to present this free webinar on February 26, 2019 to provide the herbal industry with specific details on the benefits and implementation costs of the new GRMA ANSI-accredited auditing standards.

FDA Announces New Attention to Dietary Supplement Regulations

Prominent focus on public health and safety, mandatory product listing and new dietary ingredients

AHPA submits comments on use of dairy names for plant-based product labels

On January 28, 2019, AHPA submitted comments to the Food and Drug Administration (FDA) urging the agency to ensure that any rule or guidance that the agency may adopt on the use of dairy names (e.g., “milk,” “cream,” “butter,” etc.) on the labels of plant-based products expressly does not apply to any such product that is not generally used as a substitute for or marketed to resemble a dairy product.

Revised Hemp-CBD Status Report

How hemp and CBD companies are impacted by passage of the Farm Bill

Congress passed a Farm Bill in 2018 that included historic provisions to legalize hemp, the low THC cultivars of the Cannabis sativa L. species. This landmark legislation changes how hemp and hemp-derived products like cannabidiol (CBD) are regulated in the U.S. To help the herbal products industry understand the new regulatory landscape, AHPA has expanded this Status Report and to answer industry questions about the new legal landscape.

USDA’s final rule for GMO labeling ignores recommendations of consumers and AHPA

Final rule hinders consumer access to information on genetically modified foods

The U.S. Department of Agriculture (USDA) Agricultural Marketing Service (AMS) issued a final rule on December 20 that establishes the new national mandatory bioengineered (BE) food disclosure standard. The final rule does not incorporate significant revisions recommended by AHPA and consumer groups that were aimed at ensuring U.S. consumers can discern if their food includes genetically modified organisms (GMOs) or ingredients derived from GMOs.

Nutritional supplements access preserved in Arizona

AHPA and NPA protect proper rules for safe, legal, natural products

A proposal that would have drastically limited access to safe, legal and popular products for Arizonans was changed recently thanks to the Natural Products Association (NPA) and the American Herbal Products Association (AHPA), who worked with the Arizona Board of Pharmacy and other state policymakers on the issue.
Lessons in herb safety from The Cleveland Clinic Chinese Herbal Medicine Program

Lessons in herb safety from The Cleveland Clinic Chinese Herbal Medicine Program

Clinic reports only six mild adverse events since 2014

Nationally board-certified acupuncturist and Chinese herbalist at the Cleveland Clinic Galina Roofener shared safety data and lessons learned from the Cleveland Clinic Wellness Institute’s Traditional Chinese Herbal Medicine (TCHM) Program at her keynote delivered at the American Herbal Products Association’s (AHPA’s) 7th Annual Botanical Congress presented on Nov. 10 in Las Vegas at the SupplySide West trade show.
RSS
12345678910 Last

2019 Annual Fund Sponsors

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.